Literature DB >> 7614314

The effect of comorbid conditions on hemodialysis access patency.

D W Windus1.   

Abstract

Vascular access complications are a continuing source of hospitalization and morbidity in chronic dialysis patients. Several factors have been identified that are associated with complications in patients with native vein and prosthetic bridge arteriovenous graft fistulas. Early failure of native vein arteriovenous fistulas most consistently are related to small blood vessels. It remains unclear whether other comorbid factors play a role in complications of this fistula type. Prosthetic bridge fistulas are frequently placed in the United States and are associated with frequent complications. Factors most consistently associated with higher complication rates are diabetes mellitus, older age, and black race. Antiphospholipid antibody-associated syndromes and erythropoietin therapy have also been suggested as contributing factors. In addition, elevated lipoprotein(a) and hypoalbuminemia have been found to be associated with an increase of prosthetic graft thrombosis in white and Hispanic dialysis patients. This information strongly suggests that fistula complications are multifactorial. An improved understanding of the mechanisms of these associations may aid in the delineation of the pathogenesis and an improvement in the outcome of this important problem.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7614314     DOI: 10.1016/s1073-4449(12)80045-8

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  4 in total

1.  Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients.

Authors:  Haimanot Wasse; Rebecca A Speckman; Diane L Frankenfield; Michael V Rocco; William M McClellan
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

Review 2.  Vascular access in elderly patients with end-stage renal disease.

Authors:  Nikolaos Bessias; Kosmas I Paraskevas; Effie Tziviskou; Vassilios Andrikopoulos
Journal:  Int Urol Nephrol       Date:  2008-09-16       Impact factor: 2.370

3.  Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients.

Authors:  Linda Shavit; Meyer Lifschitz; Shuko Lee; Itzchak Slotki
Journal:  Int Urol Nephrol       Date:  2010-01-10       Impact factor: 2.370

4.  Characteristics and 3-year mortality and infection rates among incident hemodialysis patients with a permanent catheter undergoing a first vascular access conversion.

Authors:  Yee-Yung Ng; Yen-Ni Hung; Shiao-Chi Wu; Po-Jen Ko
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.